Evidence map›Paper›PMID 36548381›Full record

ArticlePloS one2022

Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide.

Rute Marcelino, Ifeanyi Jude Ezeonwumelu, André Janeiro, Paula Mimoso, Sónia Matos, Veronica Briz, Victor Pimentel, Marta Pingarilho, Rui Tato Marinho, José Maria Marcelino and 2 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rute MarcelinoCentro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz, Caparica, Portugal.ORCID 0000-0002-4535-9725
Ifeanyi Jude EzeonwumeluAIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.ORCID 0000-0003-4007-2212
André JaneiroFaculdade de Medicina de Lisboa, GenoMed-Diagnósticos de Medicina Molecular, Instituto de Medicina Molecular, Lisboa, Portugal.ORCID 0000-0002-9267-2079
Paula MimosoFaculdade de Medicina de Lisboa, GenoMed-Diagnósticos de Medicina Molecular, Instituto de Medicina Molecular, Lisboa, Portugal.
Sónia MatosFaculdade de Medicina de Lisboa, GenoMed-Diagnósticos de Medicina Molecular, Instituto de Medicina Molecular, Lisboa, Portugal.
Veronica BrizLaboratory of Viral Hepatitis, National Center for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Victor PimentelGlobal Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical/Universidade Nova de Lisboa (IHMT/UNL), Lisboa, Portugal.
Marta PingarilhoGlobal Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical/Universidade Nova de Lisboa (IHMT/UNL), Lisboa, Portugal.
Rui Tato MarinhoDepartment of Gastroenterology and Hepatology, Santa Maria Hospital, Medical School of Universidade de Lisboa, Portugal.
José Maria MarcelinoCentro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz, Caparica, Portugal.
Nuno TaveiraCentro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz, Caparica, Portugal.
Ana AbecasisGlobal Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical/Universidade Nova de Lisboa (IHMT/UNL), Lisboa, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Portugal, the genetic diversity, origin of HBV and the Portuguese role in the dissemination of HBV worldwide were never investigated. In this work, we studied the epidemic history and transmission dynamics of HBV genotypes that are endemic in Portugal. HBV pol gene was sequenced from 130 patients followed in Lisbon. HBV genotype A was the most prevalent (n = 54, 41.5%), followed by D (n = 44, 33.8%), and E (n = 32, 24.6%). Spatio-temporal evolutionary dynamics was reconstructed in BEAST using a Bayesian Markov Chain Monte Carlo method, with a GTR nucleotide substitution model, an uncorrelated lognormal relaxed molecular clock model, a Bayesian skyline plot, and a continuous diffusion model. HBV subgenotype D4 was the first to be introduced in Portugal around 1857 (HPD 95% 1699-1931) followed by D3 and A2 a few decades later. HBV genotype E and subgenotype A1 were introduced in Portugal later, almost simultaneously. Our results indicate a very important role of Portugal in the exportation of subgenotypes D4 and A2 to Brazil and Cape Verde, respectively, in the beginning of the XX century. This work clarifies the epidemiological history of HBV in Portugal and provides new insights in the early and global epidemic history of this virus.

Indexed as

Hepatitis BHepatitis B virusBayes TheoremDNA, ViralGenotypeHumansPhylogenyPhylogeographyPortugalDNA, Viral

Identifiers

PMID36548381
PMCPMC9778982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.